- Home
- GROV vs VTVT Comparison
GROV vs VTVT Comparison
Compare GROV & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- VTVT
- Stock Information
- Founded
- GROV 2016
- VTVT 2015
- Country
- GROV United States
- VTVT United States
- Employees
- GROV N/A
- VTVT N/A
- Industry
- GROV Package Goods/Cosmetics
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- VTVT Health Care
- Exchange
- GROV Nasdaq
- VTVT Nasdaq
- Market Cap
- GROV 53.5M
- VTVT 56.7M
- IPO Year
- GROV N/A
- VTVT 2015
- Fundamental
- Price
- GROV $1.14
- VTVT $15.55
- Analyst Decision
- GROV Hold
- VTVT Strong Buy
- Analyst Count
- GROV 1
- VTVT 2
- Target Price
- GROV $1.20
- VTVT $35.50
- AVG Volume (30 Days)
- GROV 129.8K
- VTVT 3.2K
- Earning Date
- GROV 08-07-2025
- VTVT 08-07-2025
- Dividend Yield
- GROV N/A
- VTVT N/A
- EPS Growth
- GROV N/A
- VTVT N/A
- EPS
- GROV N/A
- VTVT N/A
- Revenue
- GROV $193,427,000.00
- VTVT $17,000.00
- Revenue This Year
- GROV N/A
- VTVT N/A
- Revenue Next Year
- GROV $6.22
- VTVT N/A
- P/E Ratio
- GROV N/A
- VTVT N/A
- Revenue Growth
- GROV N/A
- VTVT N/A
- 52 Week Low
- GROV $1.02
- VTVT $12.12
- 52 Week High
- GROV $1.95
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- GROV 39.97
- VTVT 37.38
- Support Level
- GROV $1.10
- VTVT $15.17
- Resistance Level
- GROV $1.21
- VTVT $16.61
- Average True Range (ATR)
- GROV 0.06
- VTVT 0.35
- MACD
- GROV -0.02
- VTVT 0.00
- Stochastic Oscillator
- GROV 6.90
- VTVT 24.58
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.